Effects of fluid composition in fluid injection experiments in porous media.

Experiments on fluid flow in porous media, using fluids loaded with solids of various grain sizes, have been conducted in a modified Hele-Shaw setup. This setup utilised weakly cemented porous media with specific hydraulic and mechanical properties. Fluid injection in coarse granular media with clean or low-concentration fine particles, results in infiltration only, with pressure close to the material tensile strength, while injection in finer granular material causes damage alongside infiltration, with the fluid pressure still close to the material tensile strength. When larger particle sizes or higher particle concentrations are used in the mixture, the fluid travels further within the porous medium, primarily influenced by the grain size of the granular medium. In the latter case, the Darcy flow equation with an effective permeability term can be employed to determine the pressure differential. For the largest particle sizes included in the fluid, the equation is still applicable, but the effective permeability requires adjustment for particle size within the fluid rather than the granular medium. This is crucial when the injection point is locally clogged. The experiments show that fracturing conditions are controlled by different mechanisms. Dimensional and statistical analysis was used to classify the injection pressures to regimes predicted by fracturing theory or by Darcy law with modified effective permeabilities. The findings show that both the material properties and fluid composition are important designing parameters.

Quantitative microbial risk assessment (QMRA) for setting health-based performance targets during soil aquifer treatment.

A quantitative microbial risk assessment was conducted to assess the health risks associated with the exposure of agricultural workers to tertiary treated wastewater in irrigated fields through soil ingestion in Cyprus. Three pathogenic microorganisms were chosen, particularly E. coli (bacteria), rotavirus (viruses) and Cryptosporidium. Two extreme exposure scenarios were investigated. Monte Carlo simulations were performed using input data from literature, and the model outputs were compared to the health standards of the World Health Organization (WHO). The results suggested that additional treatment is required for all pathogens to satisfy the health standards. Sensitivity analysis identified the source concentration and pathogen reduction due to soil aquifer passage as the most influential factors in the model outputs. Additional computations were performed to evaluate the minimum pathogen reduction due to soil aquifer passage so that the health targets are achieved for the 95 % of the output values. Rotavirus and Cryptosporidium were found to require more treatment than E. coli. The inclusion of these reference pathogens to the monitoring network of the local authorities is recommended, and the role of soil aquifer passage is emphasized on reducing the concentration of the contaminants.

Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids.

BACKGROUND: Human kallikrein 4 (hK4) is a proteolytic enzyme belonging to the tissue kallikrein family of serine proteases. Previous tissue expression studies have demonstrated highest KLK4 mRNA expression in prostatic tissue, but there has been only limited evidence for the presence of hK4 protein in prostate and other tissues and in corresponding biological secretions. METHODS: To investigate the concentrations of hK4 in tissues and biological fluids, we developed a new hK4-specific sandwich-type immunoassay using a monoclonal antibody as the capture reagent. RESULTS: The assay has a detection limit of 0.02 microg/L and <0.1% cross-reactivity toward any of the other 14 human kallikreins. Twelve of 40 tissue extracts prepared from various human tissues contained detectable hK4 concentrations (0.68-7143 ng/g of total protein), with healthy prostate tissue containing the highest amount of hK4. Examination of 16 malignant and 18 benign prostate tissues revealed no significant differences in hK4 protein content, and the tissues contained a wide range of values (benign, <0.02 to 801 ng/g; malignant, <0.02 to 824 ng/g). Among the biological fluids tested, seminal plasma and urine contained widely varying amounts of hK4; concentrations in 54 urine samples were <0.02 to 2.6 microg/L, whereas concentrations in 58 seminal plasma samples were 0.2-202 microg/L. Affinity purification of hK4 from seminal plasma and subsequent mass spectrometry demonstrated the secreted nature of hK4 in seminal plasma. CONCLUSIONS: hK4 is found primarily in prostate tissue and is secreted in seminal plasma. Its value as a novel prostatic biomarker needs to be defined further.